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We. have explored analogs of 2 ’ -5 t-linked andeylic acid trimer (2-5A): 3 ’ Gmethylated 2-5A, 2 ‘-end 
modified adenylate trimer with deoxyadenosine or araadenine, methyl phosphonate and methyl 
phosphorotriester analogs as potential antiviral agents. For the treatment of virus infections, 2-5A and 
its analogs may serve in lieu of interferon, however, the use of 2-SA has two serious limitations: it is 
presumed to be impermeable to most cells, and moreover, celluhu enzymes rapidIy degrade it. Methylated 
analogs of 2-5A core strongly inhibited virus growth when added directly to cells in culture. 2’-End 
modified adenylate trimer with araadenine also inhibited virus growth, however, neither 2-5A nor other 
analogs showed any significant antiviral activity. The inhibition of virus growth was not due to the toxic 
effect of these compounds on cell growth as they had no inhibitory effect on the growth of uninfected cells 
Interferon 2-5A 
1. INTRODUCTION 
Treatment of cells with interferon induces the 
synthesis of an enzyme 2-SA synthetase which, 
when activated by certain double-stranded RNAs, 
converts ATP into a series of 5 ’ -triphospho~lated 
2 ’ -5 ’ -linked oligo riboadenylates f1,2]. The ma- 
jor active component is a trimer, 5 ‘-triphosphate, 
pppA2’p5 ‘14”~’ ‘A [3]. It activates an endonu- 
clease at nM levels. This endonuclease-mediated 
degradation of RNA has been suggested as a 
mechanism by which interferon exerts its anti- 
cellular and antiviral effects [1,2]. However, a 
direct evaluation of anticellular or antiviral effect 
of 2-SA has not been possible because of its polar 
nature which makes it impermeable to most cells. 
Attempts have been made to introduce 2-SA and 
its analogs into cells made permeable by hyper- 
tonic shock followed by resealing [4], or by in- 
creasing cell permeability by treatment with lyso- 
lecithin [S] or by the calcium phosphate co-precipi- 
tation technique [S-8]. Although these studies 
Inhibition, of virus growth 
revealed inhibition of both cellular and viral pro- 
tein synthesis as well as RNA synthesis and 
enhanced degradation of RNA, and in some cases 
inhibition of virus growth in cells in culture 
[5,6,8,9], they do not point to possible clinical use. 
Moreover, a cellular phosphodiesterase rapidly 
degrades 2-SA so that its biological effects are 
transient. 
Removal of the 5 ’ -triphosphate of 2-SA results 
in drastic reduction of the polar nature of this 
molecule so that it becomes permeable to cells in 
culture. Although the 2-SA core is inactive in vitro 
[ 1,2,10,11], in intact cells, it produces inhibition of 
protein synthesis, although at much higher concen- 
trations. This is presumably because in intact cells, 
kinases are thought to exist that introduce the 
5 ‘-triphosphate group in the 2-SA core mo@cule, 
although this has never been demonstrated. More- 
over, addition of 2-SA core or other analogs 
directly to cells in culture inhibits concanavalin A- 
induced mitogenesis of mouse spleen lymphocytes 
[12], growth of 3T3 cells [13,14], growth of Daudi 
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cells [ 151 and Epstein-Barr virus-induced transfor- 
mation of human lymphocytes [ 161. 
2. MATERIALS AND METHODS 
3 ‘-0-methylated 2-SA core, 2’-end modified 
adenylate trimer core with deoxyadenosine, 
araadenine and methyl phosphonate and methyl 
phosphorotriester analogs [ 18,191 were synthesized 
as described earlier. 2-5A core compound was 
procured from P-L Biochemicals. 
Mouse L929 and African green monkey kidney 
(Vero) cells were grown in Eagle’s minimum essen- 
tial medium (MEM) supplemented with 5% fetal 
calf serum. Vaccinia virus was grown in roller bot- 
tles and purified [lo]. Inhibition of virus growth 
was assayed by the inhibition of plaque formation 
in L929 cells. Mouse L-cells (0.25 x 106) were 
seeded in 35mm petri dishes with 2-mm grids and 
incubated at 37°C for 72 h to obtain a confluent 
monolayer. The monolayer was washed once with 
2 ml MEM and the cells were exposed to 2-5A 
analogs in MEM. After 1 h of incubation at 37”C, 
the medium was removed, 0.5 ml of MEM contain- 
ing vaccinia virus was added, and the dishes were 
incubated for 30 min at 37OC; the dishes were 
rocked gently every 10 min. These experiments 
were done in triplicate: control dishes received 
MEM and no virus. After virus adsorption, the 
medium was aspirated, the cells were washed with 
2 ml MEM, and 1 ml agar overlay (0.28% agarose 
in MEM, without phenol red but containing 2% 
fetal calf serum and 0.175% NaHCO3) was added. 
To the petri dishes in which the effect of 2-5A 
analogs on virus replication was studied, the com- 
pounds were also added in the agar overlay. On 
top of the agar overlay, 0.1 ml of MEM without 
phenol red but containing 2% fetal calf serum and 
0.175% NaHCO3 was added. 
After incubation for 72 h at 37”C, the plaques 
were counted in a plaque viewer (Bellco Glass) 
after staining with 0.20% crystal violet [20]. The 
amount of virus was adjusted to give 80-100 pla- 
ques/petri dish in the controls. 
The effect of 2-5A analogs on cellular growth 
was measured as follows: Mouse L-cells (0.25 x 
10”) were seeded in 35-mm petri dishes and in- 
cubated at 37°C. After 24 h the monolayer was 
washed with 2 ml MEM. Fresh medium (with or 
without 2-5A methylated core analogs) was added 
to growing L-cells and incubation continued at 
37% After 24-48 h, the medium was aspirated, 
the cells were removed by trypsin and counted for 
viability by trypan blue exclusion. All determina- 
tions for cell viability were made in triplicate 
cultures. 
3. RESULTS AND DISCUSSION 
Table 1 shows that non-phosphorylated 3 I-O- 
methylated analogs of 2-5A, methylated at the ter- 
minal 3 ‘-OH or methylated at all 3 hydroxyl 
groups, when added directly to the culture medi- 
um, strongly inhibited replication of vaccinia 
virus, as measured by inhibition of plaque forma- 
tion. The analog methylated only at the 3 ‘-term- 
inal 3 ‘-hydroxyl group was more active than the 
compound methylated at all 3 ‘-hydroxyl groups. 
The inhibition of virus growth was not due to their 
toxic effect on the cells as these compounds had no 
effect on the growth of uninfected L-cells (table 2). 
Besides the methylated 2-5A analogs, only the 
2’-end modified 2-5A adenylate trimer with 
araadenine-inhibited virus growth. However, 
neither the unmodified 2-5A core nor its 5 ’ -phos- 
phorylated analog, 2’-end modified 2-5A ade- 
nylate trimer with 2’ - or 3 ’ -deoxyadenosine, 
methyl phosphonate nor methyl phosphorotriester 
analogs inhibited virus growth. Several analogs of 
Table I 
Effect of different 2’-5’4inked oii~oadenyIi~ acids on 
vaccinia virus growth in L-cells 
Additions Cont. 
GM) 
% Inhibition 
of virus 
growth 
PAAA 
PPPAAA 
AAAm 
AmAmAm 
AA2’dA 
AA3’da 
AAaraA 
3 ’ dACHsdACH3dA 
3 ’ dAOCH3dAOCH3dA 
50 0 
20 0 
20 0 
1 37 
5 50 
10 60 
25 83 
25 55 
50 20 
50 10 
50 50 
50 11 
50 6 
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Table 2 
Effect of 2’ -5 ’ -linked oligoandeylic acid on the growth 
of L-cells 
Additions 
None 
AAAm (10pM) 
AmAmAm (25 PM) 
Viable cells (X 10”) after 
24 h 48 h 
1.56 2.94 
1.68 2.84 
1.83 3.41 
2-5A have been recently synthesized [17-19, 
21-261 to increase the biological stability of 2-5A, 
as it is rapidly degraded by cellular phospho- 
diesterase [ 1,2], thus limiting its efficacy. Both the 
xylo [14] and the cordycepin 2-5A analogs 
[ 14,16,21] show increased resistance to hydrolysis 
and consequently increased efficacy in inhibiting 
cell growth. The analog of 2-5A methylated at the 
3 ‘-terminal 3 ’ -hydroxyl is also more resistant to 
degradation and causes more prolonged inhibition 
of protein synthesis when introduced into cells by 
the calcium phosphate coprecipitation technique 
[7]. The 2-5A analog methylated at all 3 hydroxyl 
groups was inactive under these conditions [7]. 
Since both the mono- and trimethylated 2-5A core 
analogs inhibited virus growth as shown in table 1, 
these compounds may be inhibiting virus growth 
by a mechanism different from the 2-5A activated 
endonuclease. The inhibition of DNA synthesis by 
the nonphosphorylated 2-5A, its xylo and cordy- 
cepin analogs lend support to this hypothesis 
[12,14]. 
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